Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
Objective: Lack of effective therapies remains a problem in the treatment of oral squamous cell carcinoma (OSCC), especially in patients with advanced tumors. OSCC development is driven by multiple aberrancies within the cell cycle pathway, including amplification of cyclin D1 and loss of p16. Hence...
Saved in:
Main Authors: | Zainal, Nur Syafinaz, Lee, Bernard Kok Bang, Wong, Zheng Wei, Chin, Iuan Sheau, Yee, Pei San, Gan, Chai Phei, Mun, Kein Seong, Rahman, Zainal Ariff Abdul, Silvio Gutkind, J., Patel, Vyomesh, Cheong, Sok Ching |
---|---|
Format: | Article |
Published: |
Chinese Anti-cancer Association
2019
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/22928/ https://doi.org/10.20892/j.issn.2095-3941.2018.0257 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of palbociclib in oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
by: Zainal, Nur Syafinaz, et al.
Published: (2019) -
Evaluation of palbociclib in oral squamous cell carcinoma and the role of PIK3CA in conferring resistance / Nur Syafinaz Zainal
by: Nur Syafinaz, Zainal
Published: (2019) -
Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models
by: Yee, Pei San, et al.
Published: (2019) -
PIK3CA gene mutations in breast carcinoma in Malaysian patients
by: Leong, Vincent Ching Shian, et al.
Published: (2008) -
Over-expression of MAGED4B increases cell migration and growth in oral squamous cell carcinoma and is associated with poor disease outcome
by: Chong, Chan Eng, et al.
Published: (2012)